Eslicarbazepine Acetate
NDC 67877-588, Eslicarbazepine Acetate, tablet, from Ascend Laboratories, LLC.
- Product NDC
- 67877-588
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211199
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-588 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ESLICARBAZEPINE ACETATE800 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-588-30 | 67877058830 | 30 TABLET in 1 BOTTLE (67877-588-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/28efe9d2-9d7b-4a7c-8458-098456d06604NADAC price for package 67877058830
GET /v1/drugs/nadac/67877058830
Use it
Look up 67877-588 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-588 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-588. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.